Company intelligence / Profile preview

Xerys Funds

Paris, Ile-de-France, France

Ownership: Private
Development stage: Other

Overview

Xerys Invest is a French private equity and portfolio management firm, not a drug-development biotech or pharma company. The term "Xerys Funds" refers to the investment vehicles managed by Xerys rather than a standalone operating life sciences company. Xerys invests across health, life sciences, and GreenTech, and has backed companies such as Advanced BioDesign, AlzProtect, and Biolog-id. For a biotech analyst, Xerys is best understood as a sector-focused financial sponsor and controlling or significant shareholder in selected healthcare and technology companies, rather than a therapeutic product developer.

Industry: Investors

Partnerships

Biolog-idAdvanced BioDesignAlzProtectSkytechPowiDian

Beyond the preview

Go deeper on Xerys Funds.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xerys Funds.

Explore the full profile